Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D

Clinica Chimica Acta

Volumn 425, Issue , 2013, Pages 192-195

  Iqbal, Mohammad Perwaiz ^a   Mehboobali, Naseema ^a   Azam, Iqbal ^a   Tareen, Asal Khan ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Pakistan)

Author keywords

Acute myocardial infarction; Alkaline phosphatase; Bone alkaline phosphatase; Coronary heart disease; Hypovitaminosis D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ACUTE MYOCARDIAL INFARCTION; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALP; ALT; AMI; BONE ALKALINE PHOSPHATASE; CORONARY HEART DISEASE; HYPOVITAMINOSIS D; MAOR; MATCHED ADJUSTED ODDS RATIO; MATCHED ODDS RATIO; MI; MOR; MYOCARDIAL INFARCTION; NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES; NICVD; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BONE AND BONES; CALCIUM; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARATHYROID HORMONE; RISK FACTORS; SMOKING; TRIGLYCERIDES; VITAMIN D DEFICIENCY;

EID: 84883407449     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.08.009     Document Type: Article

References (25)

1. Sokol S.I., Tsang P., Aggarwal V., Melamed M.L., Srinivas V.S. Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 2011, 19(4):192-201.
2. Motiwala S.R., Wang T.J. Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens 2011, 20(4):345-353. 10.1097/MNH.0b13e3283474985.
3. Reddy Vanga S., Good M., Howard P.A., Vacek J.L. Role of vitamin D in cardiovascular health. Am J Cardiol 2010, 106(6):798-805.
4. Rodriguez G., Starr A.Z., Czernuszewicz G.Z., et al. Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest 2011, 41(12):1299-1309. 10.1111/j.1365-2362.2011.02540.x.
5. Messenger W., Nielson C.M., Li H., Beer T., Barrett-Connor E., Stone K., Shannon J. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 2011, 10.1016/j.numecd.2010.10.019.
6. Jafary M.H., Samad A., Ishaq M., Jawaid S.A., Ahmad M., Vohra E.A. Profile of acute myocardial infarction (AMI) in Pakistan. Pak J Med Sci 2007, 23(4):485-489.
7. Masood S.H., Iqbal M.P. Prevalence of vitamin D deficiency in South Asia. Pak J Med Sci 2008, 24(6):891-897.
8. Mahmood K., Akhtar S.T., Talib A., Haider I. Vitamin-D status in a population of healthy adults in Pakistan. Pak J Med Sci 2009, 25(4):545-550.
9. Farley J.R., Hall S.L., Herring S., Libanati C., Wergedal J.E. Reference standards for quantification of skeletal alkaline phosphatase activity in serum by heat inactivation and lectin precipitation. Clin Chem 1993, 39:1878-1884.
10. Mahjoub S., Roudsari J.M. Quantification of bone and liver alkaline phosphatase isoenzymes with heat inactivation and phenylalanine (Phe) inhibition techniques: comparison of two methods. World Appl Sci J 2012, 17(8):941-946.
11. Lee J.H., Gadi R., Spertus J.A., Tang F., O'Keefe J.H. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol 2011, 107(11):1636-1638.
12. Manson J.E. New IOM report on vitamin D intakes: what clinicians need to know? [Last accessed June 12, 2013]. http://www.medscape.com/viewarticle/733856.
13. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008, 168(11):1174-1180.
14. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52(24):1949-1956.
15. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the TromsØ Study. Eur J Cardiovasc Prev Rehabil 2004, 11(1):69-74.
16. Grandi N.C., Breitling L.P., Vossen C.Y., et al. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 2010, 159(6):1044-1051.
17. Tonelli M., Curhan G., Pfeffer M., Sacks F., Thadhani R., Melamed M.L., et al. Relation between alkaline phosphatase, serum phosphate and all-cause or cardiovascular mortality. Circulation 2009, 120:1784-1792.
18. Haima P. Bone alkaline phosphatase (BAP), a biochemical marker of bone turnover. Clinical and Technical Review. Germany: Teco Medical GmbH 2011, http://www.teco-medical.ch/downloads/pdf/BAP_Monograph_English_0606.pdf. [Last accessed June 12, 2013].
19. Garnero P., Delmas P.D. Assessment of the serum levels of bone alkaline phosphatase with new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993, 77:1046-1053.
20. Park J.B., Kang D.Y., Yang H.M., et al. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. Eur Heart J 2012, 10.1093/eurheartj/ehs419.
21. Ryu W.S., Lee S.H., Kim C.K., Kim B.J., Yoon B.W. Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 2010, 75(22):1995-2002.
22. Shantouf R., Kovesdy C.P., Kim Y., et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2009, 4:1106-1114.
23. Iqbal M.P., Shafiq M., Mehboobali N., Iqbal S.P., Abbasi K. Variability in lipid profile in patients with acute myocardial infarction from two tertiary care hospitals in Pakistan. J Pak Med Assoc 2004, 54(11):544-549.
24. Iqbal M.P., Shafiq M., Mehboobali N., Iqbal S.P., Abbasi K., Kazmi K.A. Hypertriglyceridemia and low HDL-cholesterol are the major lipid abnormalities in normal Pakistani adults: are these contributing to the high rates of coronary artery disease in this population?. Pak J Med Sci 2004, 20(4):385-391.
25. Ishaq M., Beg M.S., Ansari S.A., Hakeem A., Ali S. Coronary artery disease risk profiles at a specialized tertiary care centre in Pakistan. Pak J Cardiol 2003, 14(2):61-68.